Find More Contacts for Ultragenyx Pharmaceutical
Protected Content
Admin, Admin, Finance, Executive Director
Director, Executive Finance
4 emails found 3 phone numbers found
View contacts for Ultragenyx Pharmaceutical to access new leads and connect with decision-makers.
View All Contacts
  • Number of Exits 
  • Contact Email info@ultragenyx.com
  • Phone Number +1 415 483 8800

Ultragenyx Pharmaceutical develops therapeutics for rare diseases, sometimes referred to as Orphan products. Ultragenyx is a efficient and effective development strategies are essential for success in the rare disease space, in which information may be incomplete or ambiguous, and few development precedents exist. The management team's

experience in selecting and developing products with clear mechanisms of action for untreated rare diseases will help Ultragenyx create life-changing therapeutics by leveraging existing yet undeveloped science for these little-known indications.

Lists Featuring This Company

Pharmaceutical Companies With More Than 50 Employees
9,752 Number of Organizations • $418.8B Total Funding Amount • 7,794 Number of Investors
San Francisco Bay Area Public Companies With More Than 100 Employees
413 Number of Organizations • $389.6B Total Funding Amount • 4,532 Number of Investors
Pharmaceutical Companies With More Than 100 Employees
6,550 Number of Organizations • $379.7B Total Funding Amount • 5,392 Number of Investors
California Companies With More Than 50 Employees (Top 10K)
9,681 Number of Organizations • $1.3T Total Funding Amount • 52,570 Number of Investors

Frequently Asked Questions

Where is Ultragenyx Pharmaceutical's headquarters? Ultragenyx Pharmaceutical is located in Novato, California, United States.Who invested in Ultragenyx Pharmaceutical? Ultragenyx Pharmaceutical has 9 investors including Takeda Ventures and Takeda.How much funding has Ultragenyx Pharmaceutical raised to date? Ultragenyx Pharmaceutical has raised .When was the last funding round for Ultragenyx Pharmaceutical? Ultragenyx Pharmaceutical closed its last funding round on Oct 18, 2023 from a Post-IPO Equity round.Who are Ultragenyx Pharmaceutical's competitors? Alternatives and possible competitors to Ultragenyx Pharmaceutical may include Vertex PharmaceuticalsAlloVir, and EyePoint Pharmaceuticals.